JP2005524660A - N−アリール−2−オキサゾリジノン−5−カルボキサミドおよびその誘導体ならびに抗細菌剤としてのそれらの使用 - Google Patents

N−アリール−2−オキサゾリジノン−5−カルボキサミドおよびその誘導体ならびに抗細菌剤としてのそれらの使用 Download PDF

Info

Publication number
JP2005524660A
JP2005524660A JP2003571259A JP2003571259A JP2005524660A JP 2005524660 A JP2005524660 A JP 2005524660A JP 2003571259 A JP2003571259 A JP 2003571259A JP 2003571259 A JP2003571259 A JP 2003571259A JP 2005524660 A JP2005524660 A JP 2005524660A
Authority
JP
Japan
Prior art keywords
oxo
oxazolidinecarboxamide
alkyl
dihydro
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003571259A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005524660A5 (enExample
Inventor
リチャード・シー・トマス
トーニー−ジョー・ポウル
マイクル・アール・バルバチン
ミーハイル・エフ・ゴーディーフ
ゲアリー・ダブルユー・ルーア
アダム・レンスロウ
ウーピンダー・シン
Original Assignee
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファルマシア・アンド・アップジョン・カンパニー・エルエルシー filed Critical ファルマシア・アンド・アップジョン・カンパニー・エルエルシー
Publication of JP2005524660A publication Critical patent/JP2005524660A/ja
Publication of JP2005524660A5 publication Critical patent/JP2005524660A5/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2003571259A 2002-02-25 2003-02-24 N−アリール−2−オキサゾリジノン−5−カルボキサミドおよびその誘導体ならびに抗細菌剤としてのそれらの使用 Pending JP2005524660A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35949502P 2002-02-25 2002-02-25
PCT/US2003/003125 WO2003072553A1 (en) 2002-02-25 2003-02-24 N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials

Publications (2)

Publication Number Publication Date
JP2005524660A true JP2005524660A (ja) 2005-08-18
JP2005524660A5 JP2005524660A5 (enExample) 2006-04-13

Family

ID=27766097

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003571259A Pending JP2005524660A (ja) 2002-02-25 2003-02-24 N−アリール−2−オキサゾリジノン−5−カルボキサミドおよびその誘導体ならびに抗細菌剤としてのそれらの使用

Country Status (36)

Country Link
US (1) US6919329B2 (enExample)
EP (1) EP1478629B1 (enExample)
JP (1) JP2005524660A (enExample)
KR (1) KR100613532B1 (enExample)
CN (1) CN1639135A (enExample)
AP (1) AP1902A (enExample)
AR (1) AR038536A1 (enExample)
AT (1) ATE342258T1 (enExample)
AU (1) AU2003210807A1 (enExample)
BR (1) BR0307924A (enExample)
CA (1) CA2476038A1 (enExample)
CO (1) CO5611128A2 (enExample)
CY (1) CY1105797T1 (enExample)
DE (1) DE60308998T2 (enExample)
DK (1) DK1478629T3 (enExample)
EA (1) EA007490B1 (enExample)
EC (1) ECSP045245A (enExample)
ES (1) ES2271615T3 (enExample)
GE (1) GEP20074198B (enExample)
HR (1) HRP20040717A2 (enExample)
IS (1) IS7376A (enExample)
MA (1) MA27180A1 (enExample)
MX (1) MXPA04008205A (enExample)
MY (1) MY135233A (enExample)
NO (1) NO20044062L (enExample)
NZ (1) NZ534521A (enExample)
OA (1) OA12779A (enExample)
PL (1) PL372461A1 (enExample)
PT (1) PT1478629E (enExample)
SI (1) SI1478629T1 (enExample)
TN (1) TNSN04163A1 (enExample)
TW (1) TW200305568A (enExample)
UA (1) UA80112C2 (enExample)
WO (1) WO2003072553A1 (enExample)
YU (1) YU72804A (enExample)
ZA (1) ZA200406362B (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007114326A1 (ja) 2006-03-31 2007-10-11 Research Foundation Itsuu Laboratory ヘテロ環を有する新規化合物
WO2009044777A1 (ja) 2007-10-02 2009-04-09 Research Foundation Itsuu Laboratory 7員ヘテロ環を有するオキサゾリジノン誘導体
JP5207382B2 (ja) * 2006-08-30 2013-06-12 塩野義製薬株式会社 ウレア誘導体
WO2019163731A1 (ja) * 2018-02-26 2019-08-29 住友化学株式会社 オキサゾリジノン化合物の製造方法

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
US7105547B2 (en) 2002-10-10 2006-09-12 Pharmacia And Upjohn Company Antimicrobial 1-aryl dihydropyridone compounds
CA2521685A1 (en) * 2003-04-09 2004-10-21 Pharmacia & Upjohn Company Llc Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
MXPA05013132A (es) 2003-06-03 2006-05-25 Rib X Pharmaceuticals Inc Compuestos heterociclicos de biarilo y metodos de produccion y su uso.
JP4607107B2 (ja) 2003-07-02 2011-01-05 メルク・シャープ・エンド・ドーム・コーポレイション シクロプロピル基置換されたオキサゾリジノン抗生物質およびこれらの誘導体
US20060247286A1 (en) * 2003-07-02 2006-11-02 Milton Hammond Oxazolidinone antibiotics and derivatives thereof
TW200526626A (en) 2003-09-13 2005-08-16 Astrazeneca Ab Chemical compounds
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
JP2007514782A (ja) 2003-12-17 2007-06-07 リブ−エックス ファーマシューティカルズ,インコーポレイテッド ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
WO2005082900A2 (en) * 2004-01-28 2005-09-09 Pharmacia & Upjohn Company Llc Oxazolidinone amidoximes as antibacterial agents
WO2006016221A1 (en) * 2004-08-06 2006-02-16 Pharmacia & Upjohn Company Llc Oxazolidinones containing oxindoles as antibacterial agents
JP2008521792A (ja) * 2004-11-29 2008-06-26 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌薬としてのジアゼピンオキサゾリジノン
EE05394B1 (et) * 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
US8399489B2 (en) 2005-02-18 2013-03-19 Astrazeneca Ab Antibacterial piperdine derivatives
AU2006231919A1 (en) 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
EP1874782A1 (en) 2005-04-15 2008-01-09 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
JP5534497B2 (ja) 2005-06-08 2014-07-02 メリンタ セラピューティクス,インコーポレイテッド トリアゾール類の合成方法
ATE449773T1 (de) 2005-06-29 2009-12-15 Pharmacia & Upjohn Co Llc Homomorpholinoxazolidinone als antibakterielle mittel
WO2007004032A1 (en) * 2005-07-06 2007-01-11 Pharmacia & Upjohn Company Llc Oxazolidiones containing cyclobutane as antibacterial agents
CA2614105A1 (en) * 2005-07-06 2007-01-11 Pharmacia & Upjohn Company Llc Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents
KR20080080211A (ko) * 2005-12-23 2008-09-02 아스트라제네카 아베 항박테리아성 피롤로피리딘, 피롤로피리미딘 및피롤로아제핀
WO2007088478A1 (en) * 2006-02-01 2007-08-09 Pfizer Products Inc. Indazole oxazolidinones as antibacterial agents
WO2008026563A1 (en) * 2006-08-30 2008-03-06 Shionogi & Co., Ltd. Hydrazine amide derivative
EP2185549B1 (en) * 2007-08-06 2018-10-03 Micurx Pharmaceuticals, Inc. Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
BRPI0917394A2 (pt) * 2008-08-18 2019-09-24 Univ Yale moduladores de mif
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
US9643922B2 (en) 2008-08-18 2017-05-09 Yale University MIF modulators
JP5662940B2 (ja) 2008-11-20 2015-02-04 パナセア バイオテック リミテッド 新規な抗微生物薬
BRPI1008829A2 (pt) 2009-02-03 2016-03-15 Trius Therapeutics forma cristalina de dihidrogenofosfato de (r)-3-(4-(2-(2-metiltetrazol-5-il) piridin-5-il)-3-fluorofenil)-5-hidroximetil oxazolidin-2-ona
CN102803224A (zh) 2009-06-26 2012-11-28 万能药生物有限公司 新的氮杂双环己烷类化合物
JP5996532B2 (ja) 2010-07-15 2016-09-21 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 有害生物防除剤としての新規複素環式化合物
UA112897C2 (uk) 2012-05-09 2016-11-10 Байєр Фарма Акцієнгезелльшафт Біциклічно заміщені урацили та їх застосування для лікування і/або профілактики захворювань
JP6671303B2 (ja) 2014-02-21 2020-03-25 ミクウルク ファーマシューティカルズ,インコーポレイテッド 治療的投与のための水溶性o−カルボニルホスホルアミダートプロドラッグ

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US5043443A (en) * 1988-07-29 1991-08-27 Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives
US5182403A (en) * 1988-09-15 1993-01-26 The Upjohn Company Substituted 3(5'indazolyl) oxazolidin-2-ones
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
US5225565A (en) * 1988-09-15 1993-07-06 The Upjohn Company Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones
EP0417044A3 (en) 1989-09-07 1991-06-12 Ciba-Geigy Ag Oxazolidinones and thiones as plantgrowth regulators
US5231188A (en) * 1989-11-17 1993-07-27 The Upjohn Company Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents
CA2119556C (en) * 1991-11-01 2004-07-06 Michael Robert Barbachyn Substituted aryl- and heteroaryl-phenyloxazolidinones
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
WO1994001110A1 (en) 1992-07-08 1994-01-20 The Upjohn Company 5'-INDOLINYL OXAZOLIDINONES USEFUL AGAINST $i(MYCOBACTERIUM TUBERCULOSIS)
FI952798L (fi) * 1992-12-08 1995-06-07 Upjohn Co Antibakteerisia troponisubstituoituja fenyylioksatsolidinoneja
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
CN1046276C (zh) * 1993-11-22 1999-11-10 法玛西雅厄普约翰美国公司 取代羟基乙酰基哌嗪苯基唑烷酮酯及其用途
JPH0873455A (ja) 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
DE4425609A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Benzofuranyl- und Benzothienyloxazolidinone
DE19514313A1 (de) * 1994-08-03 1996-02-08 Bayer Ag Benzoxazolyl- und Benzothiazolyloxazolidinone
DE4429461A1 (de) * 1994-08-19 1996-02-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DK0788498T3 (da) 1994-10-26 2001-11-05 Upjohn Co Phenyloxazolidinoner med antimikrobiel virkning
JPH10508844A (ja) * 1994-11-15 1998-09-02 ファルマシア・アンド・アップジョン・カンパニー 二環式オキサジンおよびチアジンオキサゾリジノン抗菌剤
EP0807112B1 (en) 1995-02-03 2001-09-05 PHARMACIA & UPJOHN COMPANY Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
HRP960159A2 (en) * 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
PT828741E (pt) 1995-05-11 2002-02-28 Upjohn Co Oxazolidinonas de diazinilo espirociclico e biciclico e de carbazinilo
DE69616366T2 (de) * 1995-09-01 2002-07-04 Upjohn Co Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen
DE19601265A1 (de) * 1996-01-16 1997-07-17 Bayer Ag 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone
DE19601264A1 (de) * 1996-01-16 1997-07-17 Bayer Ag Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone
DE19601627A1 (de) * 1996-01-18 1997-07-24 Bayer Ag Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
DE19604223A1 (de) * 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) * 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
US5990136A (en) * 1996-08-21 1999-11-23 Pharmacia & Upjohn Company Isoxazoline derivatives useful as antimicrobials
KR20010013192A (ko) 1997-05-30 2001-02-26 로렌스 티. 마이젠헬더 티오카보닐 작용기를 갖는 옥사졸리디논 항균제
DE19730847A1 (de) 1997-07-18 1999-01-28 Bayer Ag Tricyclisch substituierte Oxazolidinone
GB9717804D0 (en) * 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
US6083967A (en) 1997-12-05 2000-07-04 Pharmacia & Upjohn Company S-oxide and S,S-dioxide tetrahydrothiopyran phenyloxazolidinones
DE19802235A1 (de) 1998-01-22 1999-07-29 Bayer Ag Mit tricyclischen Indolen substituierte Oxazolidinone
DE19802239A1 (de) 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
CN1288462A (zh) * 1998-01-23 2001-03-21 法玛西雅厄普约翰美国公司 噁唑烷酮组合库、组合物和制备方法
DE19805117A1 (de) 1998-02-09 1999-08-12 Bayer Ag Neue Oxazolidinone mit azolhaltigen Tricyclen
WO1999064417A2 (en) 1998-06-05 1999-12-16 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
GB9821938D0 (en) 1998-10-09 1998-12-02 Zeneca Ltd Chemical compounds
CN1495181A (zh) * 1999-02-01 2004-05-12 �������Ŷ���Լ��������˾ 制备环状含硫氟的噁唑烷酮的方法
AU767380B2 (en) 1999-05-27 2003-11-06 Pharmacia & Upjohn Company Bicyclic oxazolidinones as antibacterial agent
GB9928499D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical processes and intermediates
NZ519725A (en) 1999-12-21 2004-05-28 Upjohn Co Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
GB0100110D0 (en) 2001-01-04 2001-02-14 Univ Leeds Modulation of calcium channel activity
GB0113297D0 (en) 2001-06-01 2001-07-25 Astrazeneca Ab Chemical Process
EP1451164A2 (en) * 2001-07-12 2004-09-01 PHARMACIA & UPJOHN COMPANY Amide derivatives having improved solubility

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007114326A1 (ja) 2006-03-31 2007-10-11 Research Foundation Itsuu Laboratory ヘテロ環を有する新規化合物
EP2181994A1 (en) 2006-03-31 2010-05-05 Research Foundation Itsuu Laboratory Antimicrobial compounds
JP5207382B2 (ja) * 2006-08-30 2013-06-12 塩野義製薬株式会社 ウレア誘導体
WO2009044777A1 (ja) 2007-10-02 2009-04-09 Research Foundation Itsuu Laboratory 7員ヘテロ環を有するオキサゾリジノン誘導体
EP2233484A2 (en) 2007-10-02 2010-09-29 Research Foundation Itsuu Laboratory Oxazolidinone derivatives having a 7-membered heterocyclic ring
EP2669283A1 (en) 2007-10-02 2013-12-04 Shionogi&Co., Ltd. Oxazolidinone derivative having 7-membered hetero ring
WO2019163731A1 (ja) * 2018-02-26 2019-08-29 住友化学株式会社 オキサゾリジノン化合物の製造方法
JPWO2019163731A1 (ja) * 2018-02-26 2021-02-04 住友化学株式会社 オキサゾリジノン化合物の製造方法
JP7205529B2 (ja) 2018-02-26 2023-01-17 住友化学株式会社 オキサゾリジノン化合物の製造方法

Also Published As

Publication number Publication date
DK1478629T3 (da) 2007-01-29
KR20040091668A (ko) 2004-10-28
CA2476038A1 (en) 2003-09-04
PL372461A1 (en) 2005-07-25
SI1478629T1 (sl) 2007-02-28
ES2271615T3 (es) 2007-04-16
MA27180A1 (fr) 2005-01-03
MY135233A (en) 2008-03-31
WO2003072553A8 (en) 2004-09-16
AU2003210807A1 (en) 2003-09-09
CO5611128A2 (es) 2006-02-28
US20040044052A1 (en) 2004-03-04
WO2003072553A1 (en) 2003-09-04
GEP20074198B (en) 2007-09-25
TW200305568A (en) 2003-11-01
YU72804A (sh) 2006-08-17
AR038536A1 (es) 2005-01-19
ATE342258T1 (de) 2006-11-15
OA12779A (en) 2006-07-06
ZA200406362B (en) 2006-02-22
UA80112C2 (en) 2007-08-27
IS7376A (is) 2004-07-29
EA200400893A1 (ru) 2005-02-24
CY1105797T1 (el) 2011-02-02
AP2004003110A0 (en) 2004-09-30
TNSN04163A1 (fr) 2007-03-12
BR0307924A (pt) 2004-12-07
US6919329B2 (en) 2005-07-19
DE60308998T2 (de) 2007-03-01
EP1478629B1 (en) 2006-10-11
DE60308998D1 (de) 2006-11-23
NZ534521A (en) 2007-02-23
MXPA04008205A (es) 2004-11-26
NO20044062L (no) 2004-10-26
PT1478629E (pt) 2007-01-31
ECSP045245A (es) 2004-09-28
AP1902A (en) 2008-10-15
CN1639135A (zh) 2005-07-13
HRP20040717A2 (en) 2005-02-28
KR100613532B1 (ko) 2006-08-16
EP1478629A1 (en) 2004-11-24
EA007490B1 (ru) 2006-10-27

Similar Documents

Publication Publication Date Title
EP1478629B1 (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
EP1987025B1 (en) Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents
CN101679454A (zh) 治疗细菌感染的抗菌杂环化合物
US20040014967A1 (en) Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound
US7645781B2 (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
JP3887396B2 (ja) 抗バクテリア・インドロン・オキサゾリジノン、その製造用中間体、及びそれを含有する医薬組成物
JP2006522791A (ja) 抗微生物性[3.1.0]ビシクロヘキシルフェニルオキサゾリジノン誘導体および類似体
US20040127530A1 (en) Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
US7105547B2 (en) Antimicrobial 1-aryl dihydropyridone compounds
WO2005082897A1 (en) Oxazolidinone antibacterial agents
JP2008521790A (ja) 抗菌剤としてのチアゼピンオキサゾリジノン
WO2005082900A2 (en) Oxazolidinone amidoximes as antibacterial agents
HK1009449A1 (en) Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
HK1009449B (en) Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060224

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060224

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20090210

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20090218

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20090313

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091116

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20091118

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100210

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100218

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100517